Biomarker Technologies Market Report 2026

Biomarker Technologies Market Report 2026 Market Overview

• Biomarker Technologies Market Report 2026 market size has reached to $56.62 billion in 2025 • Expected to grow to $103.12 billion in 2030 at a compound annual growth rate (CAGR) of 12.7% • Growth Driver: Growing Demand For Personalized Medicine Fueling Market Expansion Through Increasing Adoption Of Precision-Based Drug Development • Market Trend: Artificial Intelligence-Enabled Spatial Biology Platforms Advance Biomarker-Based Cancer Research • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Biomarker Technologies Market?

Biomarker technologies are tools and analytical methods used to detect and measure biological markers in the body to understand health conditions and disease progression. These technologies analyze biological samples such as blood, tissue, urine, and saliva using genomics, proteomics, metabolomics, and molecular diagnostics techniques. They help identify specific indicators linked to diseases, treatment responses, and physiological changes. The main products of biomarker technologies include consumables, instruments, services, and software. Consumables refer to reagents, kits, and laboratory materials used in biomarker testing workflows for research and clinical applications. These products are used across test types including liquid biopsy and solid biopsy and are supported by technologies such as genomics, proteomics, metabolomics, immunoassays, and bioinformatics. They are widely applied in oncology, cardiology, neurology, infectious diseases, and metabolic disorders and are utilized by end users including pharmaceutical companies, diagnostic laboratories, research institutions, contract research organizations, and biotechnology companies.

What Is The Biomarker Technologies Market Growth Forecast?

The biomarker technologies market size is expected to see rapid growth in the next few years. It will grow to $103.12 billion in 2030 at a compound annual growth rate (CAGR) of 12.7%. The growth in the forecast period can be attributed to expansion of precision medicine adoption in healthcare systems, rising demand for minimally invasive diagnostic solutions, increasing integration of multi omics based research approaches, growth in decentralized and point of care testing models, expansion of personalized treatment monitoring and therapy optimization. Major trends in the forecast period include rising demand for early disease detection through molecular marker based screening, expansion of preventive and proactive healthcare screening programs, increasing regulatory standardization and validation requirements in diagnostic testing, growth of large scale biobanking and centralized biological sample repositories, rising adoption of multi sample biological testing workflows integrating blood urine and saliva based diagnostics.

What Is The Driver Of The Biomarker Technologies Market?

The growing demand for personalized medicine is expected to propel the growth of the biomarker technologies market going forward. Personalized medicine is a healthcare approach that uses genetic, molecular, and patient-specific information to guide diagnosis, treatment selection, and disease management decisions. The demand for personalized medicine is increasing as pharmaceutical companies increasingly develop targeted therapies that require precise patient identification and biomarker-guided treatment pathways. Biomarker technologies support personalized medicine by identifying measurable biological indicators that enable targeted drug development, patient stratification, and treatment optimization. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, In 2023, the US Food and Drug Administration (FDA) granted approval for 16 new personalized treatments for rare disease patients, marking a substantial increase from the six approvals in 2022. Therefore, the growing demand for personalized medicine is driving the growth of the biomarker technologies industry.

Key Players In The Global Biomarker Technologies Market

Major companies operating in the biomarker technologies market report are Labcorp Holdings Incorporated, Illumina Incorporated, BioMérieux SA, Bruker Corporation, Bio-Rad Laboratories Incorporated, Exact Sciences Corporation, Bio-Techne Corporation, Myriad Genetics Incorporated, MDxHealth SA, Guardant Health Incorporated, Veracyte Incorporated, Tempus AI Incorporated, Meso Scale Diagnostics LLC, Adaptive Biotechnologies Corporation, Alamar Biosciences Incorporated, Burning Rock Biotech Limited, SOPHiA GENETICS SA, Seer Incorporated, Biomodal Limited, Thermo Fisher Scientific, F. Hoffmann-La Roche AG, QIAGEN N.V., Agilent Technologies Incorporated, Quest Diagnostics Incorporated

Global Biomarker Technologies Market Trends and Insights

Major companies operating in the biomarker technologies market are focusing on developing spatial biology technologies, such as artificial intelligence-enabled spatial biomarker analysis platforms, to improve cancer diagnostics and translational research capabilities. Artificial intelligence-enabled spatial biomarker analysis platforms combine tissue imaging, molecular profiling, and computational analytics to study biomarker expression and cellular interactions within tissue samples. For instance, in April 2024, Nucleai, an Israel-based biotechnology company, introduced new artificial intelligence spatial biomarker advancements at the American Association for Cancer Research 2024 conference. The technology provides automated pathology analysis, integrates spatial biology data with artificial intelligence models, and improves biomarker discovery for oncology treatment development. The platform also enables deeper characterization of the tumor microenvironment, helping researchers better understand cellular interactions that influence disease progression and treatment response. Additionally, it supports patient stratification and predictive analytics, allowing pharmaceutical and biotechnology companies to identify suitable patient populations and accelerate the development of personalized cancer therapies.

What Are Latest Mergers And Acquisitions In The Biomarker Technologies Market?

In July 2024, Thermo Fisher Scientific, a US-based provider of analytical instruments, acquired Olink Holding AB for $3.1 billion. With this acquisition, Thermo Fisher Scientific aimed to strengthen its proteomics and biomarker discovery capabilities by integrating Olink’s next-generation protein analysis platform to expand precision medicine and translational research applications. Olink Holding AB is a Sweden-based provider of proteomics solutions and biomarker discovery technologies that support disease research, drug development, and precision diagnostics.

What Defines the Biomarker Technologies Market?

The biomarker technologies market consists of revenues earned by entities by providing services such as biomarker discovery services, molecular diagnostics services, genomic and proteomic analysis services, companion diagnostics services, biomarker validation services, and clinical research testing services. The market value includes the value of related goods sold by the service provider or included within the service offering. The biomarker technologies market also includes sales of biomarker assay kits, biosensors, sequencing instruments, chromatography systems, mass spectrometry instruments, and molecular diagnostic devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities, including downstream manufacturers, wholesalers, distributors, and retailers, or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Biomarker Technologies Market Report 2026?

The biomarker technologies market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the biomarker technologies industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.